Tiziana Life Sciences Ltd
TLSA
$2.04
-$0.09-4.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.46% | 21.37% | 32.94% | 31.19% | 29.60% |
| Total Depreciation and Amortization | 45.63% | 37.69% | 29.17% | 15.23% | 1.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 77.78% | 135.70% | 209.43% | 82.69% | -8.45% |
| Change in Net Operating Assets | -174.33% | -220.93% | 65.11% | 177.49% | 216.73% |
| Cash from Operations | -123.99% | 47.59% | 90.28% | 84.39% | 79.54% |
| Capital Expenditure | 21.43% | -114.29% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 388.60% | 244.30% | -- | 0.10% | -99,900.00% |
| Cash from Investing | 383.53% | 241.81% | 98.10% | -3.20% | -101,300.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 20.53% | 3.33% | -18.49% | -38.39% | -64.13% |
| Issuance of Common Stock | 48,116.00% | 33,300.00% | 18,484.00% | 18,584.00% | -- |
| Repurchase of Common Stock | -- | 59.06% | 79.53% | 94.90% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00% | -- |
| Cash from Financing | 131,922.22% | 8,107.35% | 2,190.61% | 516.62% | 101.05% |
| Foreign Exchange rate Adjustments | 120.32% | 56.51% | -1,210.71% | -79.22% | -14.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 211.96% | 138.66% | 115.00% | 92.07% | 72.59% |